Target intelligence / Profile preview

Major capsid protein L1, Human papillomavirus type 6 (L1)

Target
L1
Molecular classification
Other (capsid protein), Structural viral protein
01

Overview

The major capsid protein L1 of Human papillomavirus type 6 is the principal structural protein forming the viral capsid, assembling into 72 pentamers that create an icosahedral structure approximately 50 nm in diameter[5][6]. L1 is essential for viral infectivity; it mediates attachment to host cells and encapsidates the ~8 kb HPV genome[1][3]. Recombinant L1 can self-assemble into highly immunogenic virus-like particles, which underlie current prophylactic HPV vaccines[3]. Neutralizing antibodies targeting specific surface loops of L1 can prevent infection by inhibiting virus attachment or entry into host cells[4]. HPV6 L1 is the immune focus in preventing diseases like genital warts and respiratory papillomatosis caused by HPV6 infection.

Other names
HPV-6 L1 proteinL1 proteinHPV6 L1
02

Mechanism of action

Induction of neutralizing antibodies that prevent viral attachment and entry; vaccines use L1 virus-like particles to stimulate immunity

03

Biological functions

Virus assemblyVirus entry (host cell attachment)Encapsidation of viral DNAInduction of immune response
04

Disease associations

Infection (linked to genital warts and recurrent respiratory papillomatosis)
05

Safety considerations

Standard vaccine-related concerns (e.g., allergic reactions, injection site reactions)no direct oncogenicity or enzymatic/toxic effects from L1 itself
06

Interacting drugs

Human papillomavirus vaccines (e.g., Gardasil)

1 more in the full profile.

07

Biomarkers

Detection of L1-specific antibodies as an indicator of immune response to vaccination/infection

Beyond the preview

Go deeper on Major capsid protein L1, Human papillomavirus type 6 (L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major capsid protein L1, Human papillomavirus type 6 (L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call